Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

American Virtual Cloud Tech Inc (AVCT)

American Virtual Cloud Tech Inc (AVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 19,417
  • Shares Outstanding, K 32,470
  • Annual Sales, $ 20,050 K
  • Annual Income, $ -161,390 K
  • 60-Month Beta 0.05
  • Price/Sales 0.21
  • Price/Cash Flow N/A
  • Price/Book 0.94
Trade AVCT with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.27
  • Most Recent Earnings $-2.27 on 11/14/22
  • Latest Earnings Date 02/13/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5491 +8.91%
on 01/19/23
1.4600 -59.04%
on 01/09/23
-0.3150 (-34.50%)
since 12/19/22
3-Month
0.5491 +8.91%
on 01/19/23
1.6500 -63.76%
on 10/20/22
-0.9620 (-61.67%)
since 10/19/22
52-Week
0.5491 +8.91%
on 01/19/23
21.4500 -97.21%
on 01/20/22
-20.7020 (-97.19%)
since 01/19/22

Most Recent Stories

More News
First Patient Dosed in the US in Avacta’s AVA6000 Phase 1 Clinical Study

Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces that the first patient has been dosed in the US under its Investigational...

AVCT.LN : 45.300 (+1.80%)
AVCT : 0.5980 (-11.01%)
Avacta Opens First Two US Clinical Investigator Sites for AVA6000 Phase 1 Clinical Study

Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces the opening on 5 April 2023 of the first two clinical investigator...

AVCT : 0.5980 (-11.01%)
Avacta Announces First Patient Dosed in Fifth Cohort of AVA6000 Phase Ia Dose Escalation Study

Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces that the first patient has been dosed in the fifth cohort of the...

AVCT.LN : 45.300 (+1.80%)
AVCT : 0.5980 (-11.01%)
Avacta Appoints Karen Harrison as Chief Operating Officer for Therapeutics Division

Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, today announced the appointment of Karen Harrison as Chief Operating Officer...

AVCT.LN : 45.300 (+1.80%)
AVCT : 0.5980 (-11.01%)
Avacta Announces Successful Completion of Fourth Dose Escalation in AVA6000 Phase 1 Clinical Study

Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics announces that AVA6000 continues to show a very favourable safety profile in...

AVCT : 0.5980 (-11.01%)
Don’t Chase American Virtual Cloud Technologies Higher

American Virtual Cloud Technologies rocketed higher to start the month but don't go chasing prices until you know the whole story.

AVCT : 0.5980 (-11.01%)
T : 16.81 (+1.88%)
IBM : 184.10 (+1.05%)
CRM : 276.19 (-0.18%)
ZM : 61.65 (+0.05%)
Pre-Market Brief: Stocks Mixed as Economic Outlook Darkens

December S&P 500 futures (ESZ22) are trending up +1.03% after three major US benchmark indices continued to fall deeper into correction territory during the regular trading session as investors fretted...

ESZ22 : 3,871.47s (-0.66%)
AMLX : 1.8800 (-3.59%)
MSFT : 409.06 (+0.37%)
NKE : 94.64 (+0.66%)
PATH : 19.70 (+0.77%)
AVCT : 0.5980 (-11.01%)
Avacta Announces AVA6000 Receives Orphan Drug Designation From the US Food and Drug Administration

Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer ® and pre|CISION™ platforms, announces that the US Food and...

AVCT.LN : 45.300 (+1.80%)
AVCT : 0.5980 (-11.01%)
Avacta Announces Phase I Clinical Study of AVA6000 to Advance to the Fourth Cohort

Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer ® and pre|CISION™ platforms, announces that the first-in-human...

AVCT : 0.5980 (-11.01%)
LG Chem Renews License Triggering Payment to Avacta

Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer ® and pre|CISION™ platforms,...

AVCT.LN : 45.300 (+1.80%)
AVCT : 0.5980 (-11.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

American Virtual Cloud Technologies Inc. provides cloud based UCaaS, Cybersecurity and IT solutions for enterprise customers, including managed service clients. American Virtual Cloud Technologies Inc., formerly known as PENSARE ACQ CP, is based in WESTFORD, Mass.

See More

Key Turning Points

3rd Resistance Point 0.7837
2nd Resistance Point 0.7270
1st Resistance Point 0.6625
Last Price 0.5980
1st Support Level 0.5413
2nd Support Level 0.4846
3rd Support Level 0.4201

See More

52-Week High 21.4500
Fibonacci 61.8% 13.4659
Fibonacci 50% 10.9995
Fibonacci 38.2% 8.5332
Last Price 0.5980
52-Week Low 0.5491

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar